Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)

Immunotherapy plays a central role in the treatment of NSCLC and biomarkers predicting response to ICIs are valuable therapeutic tools. Programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) is integral in therapy selection as its positive predictive nature to ICIs in the metastatic setting is...

Descripción completa

Detalles Bibliográficos
Autores principales: Giustini, Nicholas, Bazhenova, Lyudmila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006757/
https://www.ncbi.nlm.nih.gov/pubmed/33790679
http://dx.doi.org/10.2147/LCTT.S235102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006757/
https://www.ncbi.nlm.nih.gov/pubmed/33790679
http://dx.doi.org/10.2147/LCTT.S235102

Ejemplares similares